SLAMF7 promotes TCRαβ+ double negative T cell antitumor activity through enhancing glutamine metabolism Nan XuPeiyang FangDong Zhang Research Open access 30 October 2025 Article: 297
Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer Bo LiuWeiwei ZhangQi Wang Research Open access 28 October 2025 Article: 296
Targeting PP2A in cancer: an underrated option Fabio SaraisFinja KrempienOlia Shokraie Review Open access 27 October 2025 Article: 295
Activating NEDD4L suppresses EGFR-driven lung adenocarcinoma growth via facilitating EGFR proteasomal degradation Maojian ChenWei JiangJing Li Research Open access 21 October 2025 Article: 294
FL496, an FL118-derived small molecule, induces growth inhibition, senescence, and apoptosis of malignant pleural mesothelioma (MPM) cells, and exhibits anti-MPM tumor efficacy strikingly superior to the pemetrexed-cisplatin combination Ieman A. M. AljahdaliXiang LingFengzhi Li Research Open access 21 October 2025 Article: 293
NK-A 17E-233I: a novel competitive inhibitor of human dihydroorotate dehydrogenase (DHODH) for cancer therapy Mohammed Moustapha AnwarSalvador MeseguerM. Angeles Juanes Research Open access 17 October 2025 Article: 292
Integrated metabolomic and transcriptomic analysis identifies adipogenic differentiation of mesenchymal stem cells as a driver of chemoresistance in acute myeloid leukemia Zhipeng PanRong HuYang Chen Research Open access 17 October 2025 Article: 291
Multi-layer stratified oncology platform utilizing transcriptomics, prostate cancer organoids, and modeling of drug response Juening KangPanagiotis ChouvardasMarianna Kruithof-de Julio Research Open access 16 October 2025 Article: 290
FASN inhibits ferroptosis in breast cancer via USP5 palmitoylation-dependent regulation of GPX4 deubiquitination Zhiwen QianYing JiangYan Zhang Research Open access 14 October 2025 Article: 289
Deciphering the cellular tumor microenvironment landscape in salivary gland carcinomas using multiplexed imaging mass cytometry Marcel MayerLisa NachtsheimChristoph Arolt Research Open access 13 October 2025 Article: 288
A novel lncRNA-mediated signaling axis governs cancer stemness and splicing reprogramming in hepatocellular carcinoma with therapeutic potential Ke SiLantian ZhangWenliang Zhang Research Open access 09 October 2025 Article: 287
The cGAS‒STING pathway in colorectal cancer: bridging innate immunity and therapeutic strategies Wen-Jing LiGuang-Hui DongXiang-Shan Ren Review Open access 08 October 2025 Article: 286
SENP1 drives glycolysis and cisplatin resistance in gastric cancer via desumoylating ENO1 Yuan FangYunru GuPei Ma Research Open access 08 October 2025 Article: 285
CDK1 drives SOX9-mediated chemotherapeutic resistance in gastric cancer Marwah Al-MathkourZheng ChenWael El-Rifai Research Open access 08 October 2025 Article: 284
Co-detection of mutations and methylations in cerebrospinal fluid ctDNA for minimally-invasive diagnosis of brainstem glioma Tian LiHuan WangLiwei Zhang Research Open access 07 October 2025 Article: 283
Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response Lucie ThorelEnora DolivetLaurent Poulain Research Open access 07 October 2025 Article: 282
Cancer-associated fibroblast-derived circKLHL24 drives perineural invasion in pancreatic cancer via dual regulation of the sec31a-CXCL12 axis Tingting LiRihua HeRufu Chen Research Open access 07 October 2025 Article: 281
Peripheral nerve injury-induced remodeling of the tumor-associated macrophages promotes immune evasion in breast cancer Yongxue JiangWenfeng ZengPenghan Huang Research Open access 06 October 2025 Article: 280
TEAD3 + high-risk melanoma cells crosstalk with GAS6 + macrophages via the GAS6-TYRO3 ligand-receptor axis to modulate propionate metabolism and drive melanoma progression Yongjin FangXiaofan XuPan Zhuge Research Open access 01 October 2025 Article: 279
High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanoma Cristian AngeliDemetra PhilippidouStephanie Kreis Research Open access 01 October 2025 Article: 278
Tumor cells promote immunosuppression in ovarian cancer via a positive feedback loop with MDSCs through the SAA1–IL-1β axis Haoran HuMeiqin YangLingfei Han Research Open access 30 September 2025 Article: 277
Epigenetic regulation in gynecological cancers: a paradigm shift in immunotherapy strategies Chenyuan ZhaoYang LiuZhuo Cui Review Open access 30 September 2025 Article: 275
Mesenchymal stroma drives axonogenesis and nerve-induced aggressiveness in osteosarcoma Gemma Di PompoThimios A. MitsiadisNicola Baldini Research Open access 30 September 2025 Article: 276
Cancer-associated fibroblast promotes tamoxifen resistance in estrogen receptor positive breast cancer via exosomal LncRNA PRKCQ-AS1/miR-200a-3p/MKP1 axis-mediated apoptosis suppression Chenghui WuXi SunXiaosong Chen Research Open access 30 September 2025 Article: 274
O-GlcNAcylation of UBAP2L regulates stress granule formation and sunitinib resistance in clear cell renal cell carcinoma Jiajun XingBaochao LiChenkui Miao Research Open access 30 September 2025 Article: 273
PSMA-targeted theranostic nanoplatform achieves spatiotemporally precise therapy and triggers ferroptosis in prostate cancer treatment Linxue ZhangQi SunRuiji Liu Research Open access 30 September 2025 Article: 272
FSTL3 is a biomarker of poor prognosis and associated with immunotherapy resistance in ovarian cancer Maeva ChauvinEstelle TromelinDavid Pépin Research Open access 30 September 2025 Article: 271
MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction Marco BocchettiAlessia Maria CossuSilvia Zappavigna Research Open access 30 September 2025 Article: 270
DUSP8 as a regulator of glioblastoma stem-like cell contribution to tumor vascularization Giorgia CastellaniMariachiara BuccarelliLucia Ricci-Vitiani Research Open access 30 September 2025 Article: 269
Mechanistic models position ceritinib as a nuclear integrity disrupting therapy in pediatric liver tumors Salih DemirThomas KesslerRoland Kappler Research Open access 18 September 2025 Article: 268
Correction: HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc Zhipeng LiJialiang LiuZongli Zhang Correction Open access 15 September 2025 Article: 267
Correction: Elucidating the role of N‑myristoylation in the excessive membrane localization of PD‑L1 in hypoxic cancers and developing a novel NMT1 inhibitor for combination with immune checkpoint blockade therapy Haoming ZhaoZhen ZhangWantao Chen Correction Open access 04 September 2025 Article: 266
Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer Tinghao LiKunyao ZhuWeiyang He Research Open access 02 September 2025 Article: 265
ECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on Tregs Giovanna TalaricoMara LecchiSabina Sangaletti Research Open access 01 September 2025 Article: 264
Crosstalk between heterogeneous cancer-associated fibroblast subpopulations and the immune system in breast cancer: key players and promising therapeutic targets Lu LiuWeijun WanXiang Xu Review Open access 01 September 2025 Article: 263
Investigating the role of UBASH3B in cancer: structural relevance, physiological functions, and therapeutic possibilities Sophie WernerCameron WestlakeDaria A. Gaykalova Review Open access 30 August 2025 Article: 262
E2F1-autophagy-ALDH1A1 axis enhances self-renewal and drug resistance of lung cancer stem-like cells in a p53-dependent manner Jingyuan LiYiyu ChenTing Ye Research Open access 30 August 2025 Article: 261
Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation Jingwen LiuJia JiangZhilei Wang Research Open access 29 August 2025 Article: 260
RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferation Arturo OrlacchioYasuko KajimuraVincenzo Coppola Research Open access 29 August 2025 Article: 259
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade Marco GreppiGiovanna TabelliniEmanuela Marcenaro Research Open access 29 August 2025 Article: 258
TRAP1 expression elicits pro-tumoral functions in macrophages associated to malignant peripheral nerve sheath tumor cells Francesca ScantamburloAlessia RubiniIonica Masgras Research Open access 28 August 2025 Article: 257
CDKN2A deletion is associated with immune desertification in diffuse pleural mesothelioma Federica TorricelliBenedetta DonatiAlessia Ciarrocchi Research Open access 28 August 2025 Article: 256
Vinburnine potentiates anti-PD1 immunotherapy in melanoma through IL-24 secretion via P38/MAPK/ATF3 signaling Susi ZhuXu ZhangCong Peng Research Open access 27 August 2025 Article: 255
A novel SOX6 + melanoma cell subtype promotes early microsatellite invasion in Asian acral melanoma through fatty acid transport disorder Chuan LvKexin ChenYue Wang Research Open access 27 August 2025 Article: 254
Functional tumor-reactive CD8 + T cells in pancreatic cancer Hongwei SunChangying ShiZhiwen Shi Research Open access 25 August 2025 Article: 253
H4K79 and H4K91 histone lactylation, newly identified lactylation sites enriched in breast cancer Jiena LiuLiuying ZhaoDa Pang Research Open access 23 August 2025 Article: 252
Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances Quinlan McLaughlinDorothy K. SojkaNan Sethakorn Review Open access 23 August 2025 Article: 251
Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities Huiyu WangXiaomin NiuShen S. Hu Review Open access 23 August 2025 Article: 250
Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer Chunfei LiWenyan ZhaoWenzheng Guan Review Open access 22 August 2025 Article: 249
B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer Giulia CattaneoMarco VentinCristina R. Ferrone Research Open access 22 August 2025 Article: 248
